BioAge Labs (BIOA) Change in Accured Expenses (2023 - 2026)

BioAge Labs has disclosed Change in Accured Expenses across 4 years of filings, most recently posting $3.9 million for Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 41.54% year-over-year to $3.9 million; the TTM figure through Jun 2026 stood at $826000.0 (down 86.64% YoY), while the FY2025 annual figure was -$3.4 million, down 173.73% from the prior year.
• Change in Accured Expenses came in at $3.9 million for Q2 2026 at BioAge Labs, up from -$3.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $8.2 million in Q3 2024 to a low of -$6.9 million in Q1 2025.
• Average Change in Accured Expenses over 4 years is $385363.6, with a median of $1.4 million recorded in 2025.
• The largest YoY upside for Change in Accured Expenses was 264.55% in 2025 against a maximum downside of 106.61% in 2025.
• Over 4 years, Change in Accured Expenses stood at $3.0 million in 2023, then decreased by 26.59% to $2.2 million in 2024, then sank by 38.71% to $1.4 million in 2025, then soared by 184.86% to $3.9 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $3.9 million in Q2 2026, -$3.8 million in Q1 2026, and $1.4 million in Q4 2025.